Top

European Journal of Clinical Microbiology & Infectious Diseases

Published in:

01-04-2004 | Article

Epidemiology of Candidaemia in Europe: Results of 28-Month European Confederation of Medical Mycology (ECMM) Hospital-Based Surveillance Study

Authors: A. M. Tortorano, J. Peman, H. Bernhardt, L. Klingspor, C. C. Kibbler, O. Faure, E. Biraghi, E. Canton, K. Zimmermann, S. Seaton, R. Grillot, the ECMM Working Group on Candidaemia

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 4/2004

Abstract

In order to update the epidemiological and mycological profile of candidaemia in Europe, the European Confederation of Medical Mycology conducted a prospective, sequential, hospital population-based study from September 1997 to December 1999. A total of 2,089 cases were documented by 106 institutions in seven European countries. Rates of candidaemia ranging from 0.20 to 0.38 per 1,000 admissions were reported. Candida albicans was identified in 56% of cases. Non-albicans Candida species were most frequently isolated from patients with haematological malignancies (65%). With increasing age, an increasing incidence of Candida glabrata was seen. The 30-day mortality rate was 37.9%. The survey results underline the burden of candidaemia in a wide range of patient populations, confirm the importance of non-albicans species, and provide baseline data for future surveillance studies at a European level.

Jarvis WR (1995) Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 20:1526–1530PubMed

Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN,Wenzel RP (1999) Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29:239–244PubMed

Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP (1988) Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 148:2642–2645PubMed

Wenzel RP, Edmond MB (2001) The impact of hospital acquired bloodstream infections. Emerg Infect Dis 7:174–177PubMed

Pelz RK, Lipsett PA, Swoboda SM, Diener-West M, Powe NR, Brower RG, Perl TM, Hammond JM, Hendrix CW (2000) Candida infections: outcome and attributable ICU costs in critically ill patients. J Intens Care Med 15:255–261CrossRef

Kao AS, Brandt ME, Pruitt WR, Conn LA, Perkins A, Stephens DS, Baughman WS, Reingold AL, Rothrock GA, Pfaller MA, Pinner RW, Hajjeh RA (1999) The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 29:1164–1170PubMed

Sandven P (2000) Epidemiology of candidemia. Rev Iberoam Micol 17:73–81

Pfaller MA, Diekema DJ (2002) Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility. J Clin Microbiol 40:3551–3557CrossRefPubMed

Launay O, Lortholary O, Bouges-Michel C, Jarrousse B, Bentata M, Guillevin L (1998) Candidemia: a nosocomial complication in adults with late-stage AIDS. Clin Infect Dis 26:1134–1141PubMed

10.

Tumbarello M, Tacconelli E, De Gaetano Donati K, Morace G, Fadda G, Cauda R (1999) Candidemia in HIV-infected subjects. Eur J Clin Microbiol lnfect Dis 18:478–483CrossRef

11.

Viscoli C, Girmenia C, Marinus A, Collette L, Martino P, Vandercam B, Doyen C, Lebau B, Spence D, Krcmery V, De Pauw B, Meunier F (1999) Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin lnfect Dis 28:1071–1079

12.

Richet H, Roux P, Des Champs C, Esnault Y, Andremont A; French candidemia study group (2002) Candidemia in French hospitals: incidence rates and characteristics. Clin Microbiol Infect 8:405–412CrossRefPubMed

13.

Grillot R (1997) Epidemiological survey of candidemia in Europe. ECMM Mycology Newsletter 0/97:12–14

14.

Donelly SM, Sullivan DJ, Shanley DB, Coleman DC (1999) Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiology 145:1871–1882PubMed

15.

Marot-Leblond A, Grimaud L, Nail S, Bouterige S, Apaire-Marchais V, Sullivan DJ, Robert R (2000) New monoclonal antibody specific for Candida albicans germ tube. J Clin Microbiol 38:61–67PubMed

16.

Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meiss JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ (2002) Defining oportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic cell transplants: an international consensus. Clin Infect Dis 34:7–14PubMed

17.

Bernhardt H, Zimmermann K, Sissolak D, Schutt-Gerwitt H, Schroder G, Enzensberger R, Willinger B, Weig M, Berns G, Grisold A, Seewald M, Ziegler E, Ruchel R, Burkhardt S, Sommer B, Graf B, Jahn B, Asboth F, Meyer L (2000) Epidemiological survey on candidemia in Europe: results of Germany and Austria. Rev Iberoam Micol 17 (Suppl 3):146–147

18.

Grillot R, Faure O, Fruit J, Sendid B, Rispail P, Datry A, Biava MF, Kures L, Morin O, Toubas D, Bretagne S, Bouteille B, Lebau B, Cassaing S, Cuisenier B, Grawey I, Poirot JL, Eloy O, Kauffmann-Lacrooix C, de Champs C, Kac G, Lavarde V, Baixench M, Bougnoux ME, Lachaud L, Lamy C, Pellet E, Biondi C (2000) ECMM prospective epidemiological survey of candidemia in Europe: report from France. Rev Iberoam Micol 17 (Suppl 3):144

19.

Klingspor L, Tornquist E, Johansson A, Petrini B, Forsum U, Hedin G (2000) ECMM’s survey of candidemia in Europe: report from Sweden. Rev Iberoam Micol 17 (Suppl 3):147

20.

Pemán J, Cantón E, Orero A, Viudes A, Frasquet J, Gobernado M (2002) Estudio multicentrico sobre la epidemiologia de las candidemias en Espana. Rev Iberoam Micol 19:30–35PubMed

21.

Tortorano AM, Biraghi E, Astolfi A, Ossi C, Tejada M, Farina C, Perin S, Bonaccorso C, Cavanna C, Raballo A, Grossi A, the FIMUA candidemia study group (2002) European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region. J Hosp Infect 51:297–304CrossRefPubMed

22.

Kibbler CC, Seaton S, Barnes RA, Gransden WR, Holliman RE, Johnson EM, Perry JD, Sullivan DJ, Wilson JA (2003) Manangement and outcome of bloostream infections due to Candida species in England and Wales. J Hosp Infect 54:18–24CrossRefPubMed

23.

Tortorano AM, Peman J, Faure O, Bernhardt H, Kibbler CC, Grillot R (2001). Bloodstream infections due to Candida species in AIDS patients: report of 63 episodes from the European Confederation of Medical Mycology (ECMM). Clin Infect Dis 33:1219

24.

Tortorano AM, Peman J, Klingspor L, Bernhardt H, Kibbler C, Faure O, Biraghi E, Canton E, Zimmmermann K, Ainscough S, Grillot R (2001) Candidaemia in premature neonates. Report of 123 episodes from the ECMM working group. Mycoses 44 (Suppl 1):76

25.

Nucci M, Colombo AL, Silveira F, Richtmann R, Salomao R, Branchini ML, Spector N (1998) Risk factors for death in patients with candidemia. Infect Control Hosp Epidemiol 19:846–850PubMed

26.

Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Rangel-Frausto MS, Rinaldi MG, Saiman L, Wiblin RT, Wenzel RP and the NEMIS Study Group (2001) Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. Clin Infect Dis 33:177–186PubMed

27.

Nucci M, Anaissie E (2001) Revisiting the source of candidemia: skin or gut? Clin Infect Dis 33:1959–1967CrossRefPubMed

28.

Wingard JR (1995) Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 20:115–125PubMed

29.

Wingard JR, Dick JD, Merz WG, Sandford GR, Saral R, Burns WH (1982) Differences in virulence of clinical isolates of Candida tropicalis and Candida albicans in mice. Infect Immun 37:833–836PubMed

30.

Oude Lashof AML, Donelly JP, Meis JFGM, Meer JWM, Kullberg BJ (2003) Duration of antifungal treatment and development of delayed complications in patients with candidaemia. Eur J Clin Microbol Infect Dis 22:43–48

31.

Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, Edwards JE (2000) Practice guidelines for the treatment of candidiasis. Clin Infect Dis 30:662–678PubMed

32.

Walsh TJ, Rex JH (2002) All catheter-related candidemia is not the same: assessment of the balance between the risks and benefits of removal of vascular catheters. Clin Infect Dis 34:600–602PubMed

33.

Wold Health Organisation (2003) Atlas of health in Europe. WHO Regional Office for Europe, Copenhagen, Denmark

Title: Epidemiology of Candidaemia in Europe: Results of 28-Month European Confederation of Medical Mycology (ECMM) Hospital-Based Surveillance Study
Authors: A. M. Tortorano
J. Peman
H. Bernhardt
L. Klingspor
C. C. Kibbler
O. Faure
E. Biraghi
E. Canton
K. Zimmermann
S. Seaton
R. Grillot
the ECMM Working Group on Candidaemia
Publication date: 01-04-2004
Publisher: Springer-Verlag
Published in: European Journal of Clinical Microbiology & Infectious Diseases / Issue 4/2004
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-004-1103-y

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Epidemiology of Candidaemia in Europe: Results of 28-Month European Confederation of Medical Mycology (ECMM) Hospital-Based Surveillance Study

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2004

African Histoplasmosis Infection with Peritoneal Involvement

Aventis Pasteur Vaccines Containing Inactivated Hepatitis A Virus: A Compilation of Immunogenicity Data

Failure of Broth-Based Tests to Detect Methicillin-Resistant Staphylococcus aureus in a Clinical Specimen

Pharmacologic Considerations in Antimicrobial Therapy, with Emphasis on Pharmacokinetics and Pharmacodynamics: Reviews for the Practicing Clinician

Antifungal Agents: In Vitro Susceptibility Testing, Pharmacodynamics, and Prospects for Combination Therapy

Efficacy of Directly Observed Treatment of HIV Infection: Experience in AIDS Welfare Homes

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page